In which congenital heart disease can phenylephrine decrease hypoxia by reducing right-to-left shunting?

In which congenital heart disease can phenylephrine decrease hypoxia by reducing right-to-left shunting?

• A. Transposition of the great arteries
• B. Tetralogy of Fallot
• C. Atrial septal defect
• D. Ventricular septal defect

Answer: (B)

Phenylephrine helps reduce hypoxia in Tetralogy of Fallot by increasing systemic vascular resistance, which shifts the pressure balance across the ventricles and the VSD. In this condition, a right-to-left shunt through the VSD occurs because the right ventricle faces obstruction of the outflow tract (RVOT) and the right-sided pressures can be high relative to the left. When you raise systemic arterial pressure with an alpha-1 agonist like phenylephrine, the left-sided pressure rises more than the right-sided pressure, decreasing the driving force for the right-to-left shunt. As less deoxygenated blood bypasses the lungs, arterial oxygenation improves, and cyanosis lessens. That’s why this drug is particularly useful during cyanotic spells in Tetralogy of Fallot. Other congenital lesions don’t rely on this right-to-left shunt mechanism that can be mitigated by increasing systemic vascular resistance, so the same effect isn’t achievable or relevant in conditions like transposition of the great arteries, atrial septal defect, or a simple ventricular septal defect.

Phenylephrine helps reduce hypoxia in Tetralogy of Fallot by increasing systemic vascular resistance, which shifts the pressure balance across the ventricles and the VSD. In this condition, a right-to-left shunt through the VSD occurs because the right ventricle faces obstruction of the outflow tract (RVOT) and the right-sided pressures can be high relative to the left. When you raise systemic arterial pressure with an alpha-1 agonist like phenylephrine, the left-sided pressure rises more than the right-sided pressure, decreasing the driving force for the right-to-left shunt. As less deoxygenated blood bypasses the lungs, arterial oxygenation improves, and cyanosis lessens.

That’s why this drug is particularly useful during cyanotic spells in Tetralogy of Fallot. Other congenital lesions don’t rely on this right-to-left shunt mechanism that can be mitigated by increasing systemic vascular resistance, so the same effect isn’t achievable or relevant in conditions like transposition of the great arteries, atrial septal defect, or a simple ventricular septal defect.